TRAW

Traws Pharma, Inc. Common Stock

1.98

USD

TRAW Earnings Reports

Positive Surprise Ratio

TRAW beat 24 of 34 last estimates.

71%

Next Report

Date of Next Report

Mar 30, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$1.94

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-100.00%

-102.03%

Traws Pharma, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, TRAW reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -9.34 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 61.20 thousand, with a --% difference.

Looking ahead to Q4 25, 3 analysts forecast an EPS of -1.94 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Traws Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Traws Pharma, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Traws Pharma, Inc. Common Stock's Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Traws Pharma, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 30, 2026.

What are the forecasts for Traws Pharma, Inc. Common Stock's next earnings report?

Based on 3 analysts, Traws Pharma, Inc. Common Stock is expected to report EPS of -$1.94 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.